These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22936009)

  • 1. The role of HDAC6 in Alzheimer's disease.
    Zhang L; Sheng S; Qin C
    J Alzheimers Dis; 2013; 33(2):283-95. PubMed ID: 22936009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease: the quest to understand complexity.
    Marques SC; Oliveira CR; Outeiro TF; Pereira CM
    J Alzheimers Dis; 2010; 21(2):373-83. PubMed ID: 20555132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation in the pathophysiology of Alzheimer's disease.
    Chouliaras L; Rutten BP; Kenis G; Peerbooms O; Visser PJ; Verhey F; van Os J; Steinbusch HW; van den Hove DL
    Prog Neurobiol; 2010 Apr; 90(4):498-510. PubMed ID: 20097254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.
    Griñán-Ferré C; Corpas R; Puigoriol-Illamola D; Palomera-Ávalos V; Sanfeliu C; Pallàs M
    J Alzheimers Dis; 2018; 62(3):943-963. PubMed ID: 29562529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC6 at the intersection of autophagy, the ubiquitin-proteasome system and neurodegeneration.
    Pandey UB; Batlevi Y; Baehrecke EH; Taylor JP
    Autophagy; 2007; 3(6):643-5. PubMed ID: 17912024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease.
    Govindarajan N; Rao P; Burkhardt S; Sananbenesi F; Schlüter OM; Bradke F; Lu J; Fischer A
    EMBO Mol Med; 2013 Jan; 5(1):52-63. PubMed ID: 23184605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic modification is linked to Alzheimer's disease: is it a maker or a marker?
    Lee J; Ryu H
    BMB Rep; 2010 Oct; 43(10):649-55. PubMed ID: 21034526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies.
    Sorrentino G; Bonavita V
    Neurol Sci; 2007 Apr; 28(2):63-71. PubMed ID: 17464468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC6 regulates aggresome-autophagy degradation pathway of α-synuclein in response to MPP+-induced stress.
    Su M; Shi JJ; Yang YP; Li J; Zhang YL; Chen J; Hu LF; Liu CF
    J Neurochem; 2011 Apr; 117(1):112-20. PubMed ID: 21235576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
    Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
    Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and epigenetics of Alzheimer's disease.
    Alagiakrishnan K; Gill SS; Fagarasanu A
    Postgrad Med J; 2012 Sep; 88(1043):522-9. PubMed ID: 22543304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics in neurodegeneration: a new layer of complexity.
    Marques SC; Oliveira CR; Pereira CM; Outeiro TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):348-55. PubMed ID: 20736041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
    Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
    Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
    Wyss-Coray T
    J Mol Neurosci; 2004; 24(1):149-53. PubMed ID: 15314264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.
    Li G; Jiang H; Chang M; Xie H; Hu L
    J Neurol Sci; 2011 May; 304(1-2):1-8. PubMed ID: 21377170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes.
    Li Y; Shin D; Kwon SH
    FEBS J; 2013 Feb; 280(3):775-93. PubMed ID: 23181831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
    Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC
    Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the p75 neurotrophin receptor in cholinergic dysfunction in Alzheimer's disease.
    Coulson EJ; May LM; Sykes AM; Hamlin AS
    Neuroscientist; 2009 Aug; 15(4):317-23. PubMed ID: 19458382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.